Showing results 2447 to 2466 of 3020
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2021 | Safety and efficacy of human milk-based fortifier in enterally fed preterm and/or low birthweight infants: a systematic review and meta-analysis | Grace, E.; Hilditch, C.; Gomersall, J.; Collins, C.T.; Rumbold, A.; Keir, A.K. |
| 2006 | Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: A review | Jacquet, J.; Begue, P.; Grimprel, E.; Reinert, P.; Sandbu, S.; Silfverdal, S.; Faldella, G.; Nolan, T.; Lambert, S.; Richmond, P.; Marshall, H.; Roberton, D.; Schuerman, L. |
| 2012 | Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial | Marshall, H.; Richmond, P.; Nissen, M.; Jiang, Q.; Anderson, A.; Jansen, K.; Reynolds, G.; Ziegler, J.; Harris, S.; Jones, T.; Perez, J. |
| 2008 | Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with Measles-Mumps-Rubella and varicella vaccines to infants 12 to 15 months of age | Nolan, T.; Bernstein, D.; Block, S.; Hilty, M.; Keyserling, H.; Marchant, C.; Marshall, H.; Richmond, P.; Yogev, R.; Cordova, J.; Cho, I.; Mendelman, P. |
| 2013 | Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents | Lambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M. |
| 2008 | Safety of bronchoalveolar lavage in young children with cystic fibrosis | Wainwright, C.; Grimshaw, K.; Carlin, J.; Vidmar, S.; Cooper, P.; Francis, P.; Byrnes, C.; Whitehead, B.; Martin, A.; Robertson, I.; Cooper, D.; Dakin, C.; Masters, I.; Massie, R.; Robinson, P.; Ranganathan, S.; Armstrong, D.; Patterson, L.; Robertson, C. |
| 2009 | Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial | Gibson, R.; Barclay, D.; Marshall, H.; Moulin, J.; Maire, J.; Makrides, M. |
| 2012 | Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial | Richmond, P.; Marshall, H.; Nissen, M.; Jiang, Q.; Jansen, K.; Garces-Sanchez, M.; Martinon-Torres, F.; Beeslaar, J.; Szenborn, L.; Wysocki, J.; Eiden, J.; Harris, S.; Jones, T.; Perez, J. |
| 2002 | Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B | Emre, S.; Terzioglu, M.; Tokatli, A.; Coskun, T.; Ozalp, I.; Weber, B.; Hopwood, J. |
| 1999 | Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes | Weber, B.; Guo, X.H.; Kleijer, W.; van de Kamp, J.; Poorthuis, B.; Hopwood, J. |
| 2000 | Saposins A,B,C, and D in plasma of patients with lysosomal storage disorders | Chang, M.; Bindloss, C.; Grabowski, G.; Qi, X.; Winchester, B.; Hopwood, J.; Meikle, P. |
| 2017 | Scale-up of lentiviral vectors for gene therapy: advances and challenges | McCarron, A.; Donnelley, M.; Parsons, D. |
| 2009 | SCARB2 Mutations in Progressive Myoclonus Epilepsy (PME) Without Renal Failure | Dibbens, L.; Michelucci, R.; Gambardella, A.; Andermann, F.; Rubboli, G.; Bayly, M.; Joensuu, T.; Vears, D.; Franceschetti, S.; Canafoglia, L.; Wallace, R.; Bassuk, A.; Power, D.; Tassinari, C.; Andermann, E.; Lehesjoki, A.; Berkovic, S. |
| 2010 | School-based prevention of depression: A 2-year follow-up of a randomized controlled trial of the beyondblue schools research initiative | Sawyer, M.; Harchak, T.; Spence, S.; Bond, L.; Graetz, B.; Kay, D.; Patton, G.; Sheffield, J. |
| 2010 | School-based prevention of depression: A randomised controlled study of the beyondblue schools research initiative | Sawyer, M.; Pfeiffer, S.; Spence, S.; Graetz, B.; Kay, D.; Patton, G.; Sheffield, J. |
| 2009 | SCN1A duplications and deletions detected in Dravet syndrome: Implications for molecular diagnosis | Marini, C.; Scheffer, I.; Nabbout, R.; Mei, D.; Cox, K.; Dibbens, L.; McMahon, J.; Iona, X.; Carpintero, R.; Elia, M.; Cilio, M.; Specchio, N.; Giordano, L.; Striano, P.; Genarro, E.; Cross, J.; Kivity, S.; Neufeld, M.; Afawi, Z.; Andermann, E.; et al. |
| 1995 | Screening for colorectal cancer - What are the costs? | Weller, D.; Moss, J.; Hiller, J.; Thomas, D.; Edwards, J. |
| 2000 | Screening for congenital dislocation of the hip - Reply | Chan, A.; Cundy, P.; Foster, B.; Keane, R.; Byron-Scott, R. |
| 2006 | Screening for lysosomal storage disorders - a clinical perspective | Fletcher, J. |
| 2011 | Screening patients referred to a metabolic clinic for lysosomal storage disorders | Fuller, M.; Tucker, J.; Lang, D.; Dean, C.; Fietz, M.; Meikle, P.; Hopwood, J. |
